If the brand is not inside that answer, the paid funnel is already leaking before the ad is served." - Ronn Torossian, founder, 5W For brands evaluating their position, 5W offers a Supplements Category AI Visibility Audit benchmarking citation share against the Index's top 25 and identifying the structural authority gaps that determine whether a brand earns mention in AI-generated consumer research.
Governments looking to reduce the costs of healthcare and boost economic productivity also need to tread carefully when encouraging the use of GLP-1 drugs in people with obesity without addressing the wider socio-economic challenges patients face as well as the problems posed by the rise in ultra-processed food and poor provision of physical exercise facilities
This frequently means that there is bleeding somewhere in the upper digestive system, which can be caused by ulcers, acid reflux, or even cancer
That's why the Obesity Medicine Association's Access and Policy Working Group says there is currently "little to no peer-reviewed evidence" supporting the safety or effectiveness of microdosed regimens for obesity
Here, GLP-1 receptor agonists are administered in controlled environments, often as part of broader treatment plans that include patient monitoring and immediate medical support
Pharmacological Reports, 73 , 1020